BEHANDLUNG EINER HEPATITIS-DELTA-VIRUSINFEKTION MIT INTERFERON-LAMBDA

Patent europeic · EP3957319 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3957319
Numer da la dumonda
EP21164362
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
17-02-2017
Publitgà
23-02-2022
Concedì
04-12-2024
La protecziun finescha il pli tard
16-02-2037
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
A61K 38/21 (2006.01)
A61P 1/16 (2006.01)
A61P 31/14 (2006.01)
Prioritad
US 201662297759 P 19.02.2016
Derivà da
EP17753966
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  2. 15-10-2025

    Midada

    Published in Swissreg on 15.10.2025

  3. 01-03-2025

    Midada

    Published in Swissreg on 01.03.2025

  4. 19-02-2025

    Represchentant inscrit

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 19.02.2025

  5. 12-02-2025

    Owner

    Owner
    Eiger InnoTherapeutics, Inc., 2061 Webster Street, Palo Alto, CA 94301, USA → EIT Pharma, Inc., 11620 Wilshire Boulevard, Suite 350, Los Angeles, CA 90025, USA

    Published in Swissreg on 12.02.2025

  6. 04-12-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.12.2024

Partidas

Inventur

MARTINS, Eduardo Bruno

Palo Alto, California 94306, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.